Lupin Limited (LUPIN) — Board Meeting

· NSE 🟡 Notable Neutral
📢 Key Event
NRC approved 65,251 stock options under Lupin Employees Stock Option Scheme 2025
🔄 What Changed
65,251 options granted at ₹2.00 exercise price with 3-year vesting schedule
🔮 What's Next
Vesting over three years subject to performance conditions
💡 Investor Takeaway
This creates potential future dilution that may pressure share price if widely exercised.

Lupin Limited announced on June 30, 2026, that its Nomination and Remuneration Committee approved granting 65,251 stock options under the Lupin Employees Stock Option Scheme 2025, effective July 1, 2026, with an exercise price of ₹2.00 per option, vesting over three years subject to performance conditions.

📄 View Original Announcement (PDF)

About Lupin Limited (LUPIN)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,04,071.47 Cr P/E: 36.2

View full LUPIN stock details →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when LUPIN files new disclosures

Track LUPIN filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track LUPIN — Free

Free account · 2 AI queries/day